Clinical trials
Phase 1 Recurrence trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Completed | 5 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 2 |
| AbbVie | 1 |
| Asan Medical Center | 1 |
| Biomea Fusion Inc. | 1 |
| Calico Life Sciences LLC | 1 |
| Celgene | 1 |
| Daiichi Sankyo | 1 |
| Genentech, Inc. | 1 |
| Genmab | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 19 |
| Leukemia, Myeloid, Acute | 4 |
| Multiple Myeloma | 4 |
| Neoplasms | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.